Curt Herberts
President chez Kriya Therapeutics, Inc.
Profil
Curt A.
Herberts is currently working as an Advisor at Bioverge Funds Management LLC.
He is also the Chief Operating Officer at Senti Sub I, Inc. since 2021 and the President & Chief Operating Officer at Kriya Therapeutics, Inc. since 2022.
Previously, he worked as the Chief Business Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2016 to 2018 and as the Chief Operating Officer at Senti Biosciences, Inc. from 2021 to 2022.
Mr. Herberts completed his undergraduate degree at Stanford University in 2003 and pursued graduate studies at Keck Graduate Institute of Applied Life Sciences.
Postes actifs de Curt Herberts
| Sociétés | Poste | Début |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Chief Operating Officer | 01/01/2021 |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | President | 25/08/2022 |
Bioverge Funds Management LLC
 Bioverge Funds Management LLC Investment ManagersFinance Bioverge Funds Management LLC (Bioverge Funds Management) is a venture capital subsidiary of Bioverge, Inc. founded in 2016 by Neil Jay Littman and Rick Gibb. The firm is headquartered in San Francisco, CA. | Consultant / Advisor | - |
Anciens postes connus de Curt Herberts
| Sociétés | Poste | Fin |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Director of Finance/CFO | 01/01/2021 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 26/05/2018 |
Formation de Curt Herberts
| Stanford University | Undergraduate Degree |
| Keck Graduate Institute of Applied Life Sciences | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bioverge Funds Management LLC
Bioverge Funds Management LLC Investment ManagersFinance Bioverge Funds Management LLC (Bioverge Funds Management) is a venture capital subsidiary of Bioverge, Inc. founded in 2016 by Neil Jay Littman and Rick Gibb. The firm is headquartered in San Francisco, CA. | Finance |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Commercial Services |
